Efficacy/Safety of Lansoprazole in Patients With Frequent Heartburn

PHASE3CompletedINTERVENTIONAL
Enrollment

576

Participants

Timeline

Start Date

June 30, 2006

Study Completion Date

January 31, 2007

Conditions
Heartburn
Interventions
DRUG

Lanzoprazole

Trial Locations (28)

10573

IRSI, Port Chester

15106

Preferred Primary Care Physicians, Carnegie

21136

Clinical Associates, Reisterstown

23226

Commonwealth Clinical Research Specialist, Richmond

23294

National Clinical Research Inc., Richmond

28144

Crescent Medical Research, Salisbury

30252

Radiant Research, Atlanta

30308

Radiant Research, Atlanta

33013

Eastern Research, Hialeah

33173

Miami Research Associates, Miami

33458

Health Awareness Inc., Jupiter

35216

Clinical Research Consultants Inc., Hoover

35802

Huntsville

37205

Nashville Medical Research, Nashville

37601

Advanced Therapeutics, Inc, Johnson City

43204

Micheal Alexander, DO, Columbus

47714

Evansville

63117

Medex Healthcare Research, Inc., St Louis

68134

Meridian Clinical Research LLC, Omaha

75243

Medical Edge Healthcare Group, P.A., Dallas

76135

Benchmark Research, Fort Worth

76904

Benchmark Research, San Angelo

85635

Radiant Research, Sierra Vista

87124

William W. Anderson M.D. P.C., Rio Rancho

90025

California Bio Medical Research Institute, Los Angeles

95678

Allergy Medical Group of North Area, Roseville

97219

New Hope Research of Oregon, Portland

98499

Radiant Research, Lakewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novartis

INDUSTRY